Last updated: 10 July 2019 at 2:32am EST

John J Alam Net Worth




The estimated Net Worth of John J Alam is at least $68.3 Millón dollars as of 1 October 2008. John Alam owns over 4,253 units of Vertex Pharmaceuticals stock worth over $66,959,703 and over the last 21 years John sold VRTX stock worth over $1,370,325.

John Alam VRTX stock SEC Form 4 insiders trading

John has made over 31 trades of the Vertex Pharmaceuticals stock since 2005, according to the Form 4 filled with the SEC. Most recently John exercised 4,253 units of VRTX stock worth $57,968 on 1 October 2008.

The largest trade John's ever made was selling 32,500 units of Vertex Pharmaceuticals stock on 7 May 2007 worth over $994,175. On average, John trades about 3,600 units every 24 days since 2003. As of 1 October 2008 John still owns at least 141,045 units of Vertex Pharmaceuticals stock.

You can see the complete history of John Alam stock trades at the bottom of the page.



What's John Alam's mailing address?

John's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE, MA, 01239.

Insiders trading at Vertex Pharmaceuticals

Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden y Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.



What does Vertex Pharmaceuticals do?

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.



Complete history of John Alam stock trades at Vertex Pharmaceuticals

Persona
Trans.
Transacción
 Precio total
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $57,968
1 Oct 2008
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $67,397
10 Sep 2008
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $67,376
3 Sep 2008
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $67,376
27 Aug 2008
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $67,376
20 Aug 2008
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $130,509
19 Jun 2008
John J Alam
SVP, Drug Eval. y Appr.
 Venta $22,151
20 May 2008
John J Alam
SVP, Drug Eval. y Appr.
 Venta $12,298
11 Dec 2007
John J Alam
SVP, Drug Eval. y Appr.
 Venta $26
16 Nov 2007
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $350,822
6 Aug 2007
John J Alam
SVP, Drug Eval. y Appr.
 Venta $25,368
17 May 2007
John J Alam
SVP, Drug Eval. y Appr.
 Venta $994,175
7 May 2007
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
31 Jan 2007
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
24 Jan 2007
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
17 Jan 2007
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
10 Jan 2007
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
3 Jan 2007
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
27 Dec 2006
John J Alam
SVP, Drug Eval. y Appr.
 Venta $76,468
13 Dec 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
6 Dec 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
29 Nov 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $27,705
22 Nov 2006
John J Alam
SVP, Drug Eval. y Appr.
 Venta $96,446
15 Nov 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $27,705
8 Nov 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $55,410
1 Nov 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $27,705
18 Oct 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $138,525
11 Oct 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $27,705
6 Sep 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $138,525
30 Aug 2006
John J Alam
SVP, Drug Eval. y Appr.
 Uso de opción $23,010
20 Dec 2005
John J Alam
SVP, Drug Eval. y Appr.
 Venta $143,393
14 Dec 2005


Vertex Pharmaceuticals executives and stock owners

Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: